2014
DOI: 10.1200/jco.2014.32.15_suppl.9647
|View full text |Cite
|
Sign up to set email alerts
|

A phase II randomized, double-blind placebo-controlled trial of an antiemetic, 6-gingerol in solid tumor patients receiving moderately to highly emetogenic adjuvant chemotherapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(11 citation statements)
references
References 0 publications
0
11
0
Order By: Relevance
“…There were no significant differences between groups regarding adverse effects (p> 0.05). (23) 2014/ Thailand Randomized, doubleblind, controlled clinical trial, n = 87.…”
Section: Design/number Of Patientsmentioning
confidence: 99%
See 4 more Smart Citations
“…There were no significant differences between groups regarding adverse effects (p> 0.05). (23) 2014/ Thailand Randomized, doubleblind, controlled clinical trial, n = 87.…”
Section: Design/number Of Patientsmentioning
confidence: 99%
“…Regarding the antiemetic action of ginger, 13 studies observed the action of ginger in nausea (14,16,(20)(21)(23)(24)(25)(26)(27)(28)(29)(30)37) ; of these, 9 (16,(23)(24)(25)(26)(27)(28)(29)(30) presented significant results considering significance level of 5% (p < 0.001 (16) ; p = 0.002 (23) ; p = 0.0001 (24) ; p = 0.04 (26) ; p = 0.0003 (27) , p = 0.003 (29)(30) ). As for emesis, 11 investigations (13,(15)(16)(20)(21)23,25,(28)(29)33,35) described advantages in this therapy, and 6 presented a result with a significance level of less than 5% (p < 0.0 01 (16,23) ; p < 0.0001 (20) ; p < 0.05 (21) ; p = 0.002 (29) ; p = 0.04 (35) ).…”
Section: Note: Flie: Functional Living Index Emesismentioning
confidence: 99%
See 3 more Smart Citations